Adverum Announces Shortened Timelines and Clear Development Path for ADVM-022 Intravitreal Gene apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Adverum Biotechnologies Announces New GMP Gene Therapy Manufacturing Facility
Adverum Biotechnologies, Inc.January 7, 2021 GMT 174,000-square-foot commercial GMP facility in Durham, NC for the manufacturing of ADVM-022, an intravitreal gene therapy in development for wet AMD and DME Multiple production suites with total capacity of 4000L, with further expansion opportunities Adverum to invest over $80M to be production-ready by end of 2023 and create more than 200 life sciences jobs; Company to receive state and local incentives of up to $9M